ETH Computer scientists have developed a new AI solution that enables touchscreens to sense with eight times higher resolution than current devices. Thanks to AI, their solution can infer much more precisely where fingers touch the screen. Quickly typing a message on a smartphone sometimes results in hitting the wrong letters on the small keyboard or on other input buttons in an app. The touch sensors that detect finger input on the touch screen have not changed much since they were first released in mobile phones in the mid-2000s. In contrast, the screens of smartphones and tablets are now providing unprecedented visual quality, which is even more evident with each new generation of devices: higher color fidelity, higher resolution, crisper contrast.

Welcome to the course where we will learn about Artificial Neural Network (ANN) From Scratch! If you're looking for a complete Course on Deep Learning using ANN that teaches you everything you need to create a Neural Network model in Python? You've found the right Neural Network course! Identify the business problem which can be solved using Neural network Models. Have a clear understanding of Advanced Neural network concepts such as Gradient Descent, forward and Backward Propagation etc.

Developments in artificial intelligence (AI) present a host of exciting opportunities for GLAMs (galleries, libraries, archives and museums) in the digital world. These range from the development of models or algorithms perfected through data processing, to mining, analysing and enriching datasets with new metadata. CC fully supports GLAMs in using the massive amounts of data in their digital collections for AI-training purposes (including machine-learning) in order to fulfil their public interest missions. This uncertainty is likely to have a chilling effect on GLAMs wishing to take advantage of AI technologies. A flowchart helps visualise whether the licenses are triggered and if so, what conditions may apply.

In my August 2020 article, "How to choose a cloud Machine Learning platform," my first guideline for choosing a platform was, "Be close to your data." Keeping the code near the data is necessary to keep the latency low, since the speed of light limits transmission speeds. After all, machine learning -- especially deep learning -- tends to go through all your data multiple times (each time through is called an epoch). I said at the time that the ideal case for very large data sets is to build the model where the data already resides, so that no mass data transmission is needed. Several databases support that to a limited extent.

Clinical workflows in oncology rely on predictive and prognostic molecular biomarkers. However, the growing number of these complex biomarkers tends to increase the cost and time for decision-making in routine daily oncology practice; furthermore, biomarkers often require tumour tissue on top of routine diagnostic material. Nevertheless, routinely available tumour tissue contains an abundance of clinically relevant information that is currently not fully exploited. Advances in deep learning (DL), an artificial intelligence (AI) technology, have enabled the extraction of previously hidden information directly from routine histology images of cancer, providing potentially clinically useful information. Here, we outline emerging concepts of how DL can extract biomarkers directly from histology images and summarise studies of basic and advanced image analysis for cancer histology. Basic image analysis tasks include detection, grading and subtyping of tumour tissue in histology images; they are aimed at automating pathology workflows and consequently do not immediately translate into clinical decisions. Exceeding such basic approaches, DL has also been used for advanced image analysis tasks, which have the potential of directly affecting clinical decision-making processes. These advanced approaches include inference of molecular features, prediction of survival and end-to-end prediction of therapy response. Predictions made by such DL systems could simplify and enrich clinical decision-making, but require rigorous external validation in clinical settings.

April was certainly a solid month for stocks, but will this month pay homage to the "Sell in May and Go Away" strategy or will we see a new trend emerge? Of course, many investors would prefer to play the long game and own high quality companies in a diversified basket of stocks via an ETF holding. While some of the below list will present some value, and some will look overseas for an advantage, all of them have been rated as our Top Buy ETFs for the month of May. These picks should help you diversify and mitigate risk inside your portfolio, and hopefully provide some upside throughout the month. Q.ai's deep learning algorithms have identified several ETFs to do some due diligence on for May, based on their fund flows over the last 90-days, 30-days, and 7-days.

The advent of Transformers in 2017 completely changed the world of neural networks. Ever since, the core concept of Transformers has been remixed, repackaged, and rebundled in several models. The results have surpassed the state of the art in several machine learning benchmarks. In fact, currently all top benchmarks in the field of natural language processing are dominated by Transformer-based models. Some of the Transformer-family models are BERT, ALBERT, and the GPT series of models.

AtomAI is an open-source software package bridging instrument-specific Python libraries, deep learning, and simulation tools into a single ecosystem. AtomAI allows direct applications of the deep convolutional neural networks for atomic and mesoscopic image segmentation converting image and spectroscopy data into class-based local descriptors for downstream tasks such as statistical and graph analysis. For atomically-resolved imaging data, the output is types and positions of atomic species, with an option for subsequent refinement. AtomAI further allows the implementation of a broad range of image and spectrum analysis functions, including invariant variational autoencoders (VAEs). The latter consists of VAEs with rotational and (optionally) translational invariance for unsupervised and class-conditioned disentanglement of categorical and continuous data representations. In addition, AtomAI provides utilities for mapping structure-property relationships via im2spec and spec2im type of encoder-decoder models. Finally, AtomAI allows seamless connection to the first principles modeling with a Python interface, including molecular dynamics and density functional theory calculations on the inferred atomic position. While the majority of applications to date were based on atomically resolved electron microscopy, the flexibility of AtomAI allows straightforward extension towards the analysis of mesoscopic imaging data once the labels and feature identification workflows are established/available. The source code and example notebooks are available at https://github.com/pycroscopy/atomai.

Accurate and explainable health event predictions are becoming crucial for healthcare providers to develop care plans for patients. The availability of electronic health records (EHR) has enabled machine learning advances in providing these predictions. However, many deep learning based methods are not satisfactory in solving several key challenges: 1) effectively utilizing disease domain knowledge; 2) collaboratively learning representations of patients and diseases; and 3) incorporating unstructured text. To address these issues, we propose a collaborative graph learning model to explore patient-disease interactions and medical domain knowledge. Our solution is able to capture structural features of both patients and diseases. The proposed model also utilizes unstructured text data by employing an attention regulation strategy and then integrates attentive text features into a sequential learning process. We conduct extensive experiments on two important healthcare problems to show the competitive prediction performance of the proposed method compared with various state-of-the-art models. We also confirm the effectiveness of learned representations and model interpretability by a set of ablation and case studies.

Facial phenotyping has recently been successfully exploited for medical diagnosis as a novel way to diagnose a range of diseases, where facial biometrics has been revealed to have rich links to underlying genetic or medical causes. In this paper, taking Parkinson's Diseases (PD) as a case study, we proposed an Artificial-Intelligence-of-Things (AIoT) edge-oriented privacy-preserving facial diagnosis framework to analyze the treatment of Deep Brain Stimulation (DBS) on PD patients. In the proposed framework, a new edge-based information theoretically secure framework is proposed to implement private deep facial diagnosis as a service over a privacy-preserving AIoT-oriented multi-party communication scheme, where partial homomorphic encryption (PHE) is leveraged to enable privacy-preserving deep facial diagnosis directly on encrypted facial patterns. In our experiments with a collected facial dataset from PD patients, for the first time, we demonstrated that facial patterns could be used to valuate the improvement of PD patients undergoing DBS treatment. We further implemented a privacy-preserving deep facial diagnosis framework that can achieve the same accuracy as the non-encrypted one, showing the potential of our privacy-preserving facial diagnosis as an trustworthy edge service for grading the severity of PD in patients.